Moors & Cabot, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$203,000
-38.7%
2,8000.0%0.01%
-40.0%
Q4 2021$331,000
+24.0%
2,800
+40.0%
0.02%
+17.6%
Q3 2021$267,000
-17.6%
2,0000.0%0.02%
-26.1%
Q2 2021$324,000
+76.1%
2,000
-81.0%
0.02%
-8.0%
Q1 2019$184,000
-33.1%
10,550
+8.8%
0.02%
-26.5%
Q3 2018$275,000
-1.4%
9,700
-4.9%
0.03%
-10.5%
Q2 2018$279,00010,2000.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders